What is GRFS stock price today?

Visit our real-time dashboard for the current GRFS stock price and live market data.

Is GRFS stock going up or down today?

GRFS stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy GRFS stock now?

The decision to buy GRFS depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is GRFS a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for GRFS based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is GRFS stock overvalued or undervalued?

GRFS currently trades at a P/E ratio of 10.76, which may suggest attractive valuation. Our DCF calculator provides intrinsic value estimates to help determine if GRFS is fairly priced.

What is GRFS's P/E ratio?

GRFS has a price-to-earnings (P/E) ratio of 10.76, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is GRFS's market cap?

GRFS (Grifols SA ADR) has a market capitalization of $5.20 billion, making it a small-cap stock.

What is GRFS's price to book ratio?

Price-to-book ratio for GRFS is available on our dashboard along with other valuation metrics.

Does GRFS pay dividends?

Yes, GRFS pays dividends with a current yield of 2.30%. Dividend payments provide income for investors in addition to potential stock price appreciation.

What is GRFS's dividend yield?

GRFS's dividend yield is 2.30%, calculated as annual dividends divided by the current stock price. This represents the annual return from dividends alone.

Is GRFS stock a good long-term investment?

GRFS's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is GRFS's revenue growth rate?

Revenue growth data for GRFS is available on our dashboard with detailed financial statement analysis.

Profitability metrics for GRFS are available on our dashboard with complete income statement analysis.

What are the risks of investing in GRFS?

Key risks for GRFS include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does GRFS compare to its competitors?

Compare GRFS to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize GRFS's performance and positioning.

What is GRFS's stock price target for 2026?

Visit our prediction page for AI-powered price targets for GRFS with bull, base, and bear case scenarios.

What do analysts say about GRFS?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for GRFS. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is GRFS's next earnings report?

GRFS reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

GRFS - Grifols SA ADR

NYSE * Healthcare * Drug Manufacturers - General

$0.00

+$0.00 (+0.00%)

About Grifols SA ADR

Grifols SA ADR (GRFS) common stock

Price Chart

Loading chart...

GRFS Key Statistics

Market Cap

$5.20B

P/E Ratio

10.76

Dividend Yield

2.30%

How GRFS Compares to Peers

GRFS has the lowest P/E ratio in Drug Manufacturers - General, suggesting it may be the most undervalued

GRFS is the smallest among peers, which may offer higher growth potential

P/E Rank

of 6

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
GRFS(This stock)	$5.20B	10.8	0%	0.0%	-
LLYEli Lilly	$991.62B	39.5	0%	0.0%	vs LLY
JNJJohnson &	$375.37B	17.4	0%	0.0%	vs JNJ
PFEPfizer Inc	$147.73B	19.8	0%	0.0%	vs PFE
MRKMerck &	$285.12B	32.5	0%	0.0%	vs MRK
ABBVAbbVie Inc	$334.34B	80.5	0%	0.0%	vs ABBV

Data Updated: July 20, 2026 at 3:20 PM EDT

Ready to invest in GRFS?

Commission-free trading available. Affiliate links.

Upcoming Events for GRFS

Dashboard

Enter a ticker to analyze